Otonomy Inc

Otonomy is a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. The company pioneered the application of drug delivery technology to the ear in order to develop products that achieve sustained drug exposure from a single local administration. This approach is covered by a broad patent estate and is being utilized to develop a pipeline of products addressing important unmet medical needs with a focus on hearing loss and tinnitus.

A scientifically sound approach
to improve the lives of patients with hearing disorders
Over the last decade, we have established the leading drug development company in neurotology. Our broad pipeline addresses tinnitus and hearing loss, conditions that impact tens of millions of people.

In order to treat hearing disorders, we work to understand the underlying biology, identify a potential treatment and deliver the drug to where it’s needed. Our scientists are experts in the microscopic realm of cochlear hair cells and spiral ganglion neurons—true miracles of biology with their specialized structures and functions.